Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Verve Therapeutics Inc
Swot
Verve Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Verve Therapeutics Inc has 17 Strengths, 17 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(17)
Weakness
(17)
Opportunity
(2)
Threats
(1)
Others
(0)
Positive Breakout Third Resistance ( LTP > R3)
Significant (over 30%) distance from 52 week high
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Increasing Revenue every Quarter for the past 8 Quarters
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Positive Breakout (LTP > R1)
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs decreased their shareholding last quarter
